価格表

在庫・価格 : 2024年04月29日 20時04分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Nanog, Rabbit-Poly
データシート
NB100-58842 NOVノバス バイオロジカルス
Novus biologicals, LLC
0.1 ml ¥103,000
(未発注)
追加

在庫・価格 : 2024年04月29日 20時04分 現在

Anti-Nanog, Rabbit-Poly

  • 商品コード:NB100-58842
  • メーカー:NOV
  • 包装:0.1ml
  • 価格: ¥103,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Castiglioni V et al. Induced pluripotent stem cell lines from Huntington"s disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway. Neurobiol. Dis. 2012 Apr;46(1):30-40
Castiglioni V et al
2012/01/01
PubMed
2 Mari坦n RM et al. Suv4-20h abrogation enhances telomere elongation during reprogramming and confers a higher tumorigenic potential to iPS cells. PLoS ONE 2011;6(10):e25680
Mari坦n RM et al
2011/01/01
PubMed
3 Camnasio S et al. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington"s disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol. Dis. 2012 Apr;46(1):41-51
Camnasio S et al
2012/01/01
Applications: ICC, IF, Species: Human PubMed
4 Liu SP et al. n-Butylidenephthalide (BP) maintains stem cell pluripotency by activating Jak2/Stat3 pathway and increases the efficiency of iPS cells generation. PLoS ONE 2012;7(9):e44024
Liu SP et al
2012/01/01
Applications: ICC/IF PubMed
5 Bertacchi M et al. The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. Cell. Mol. Life Sci. 2012 Oct;
Bertacchi M et al
2012/01/01
Species: Mouse, Applications: ICC/IF PubMed
6 Villasante A et al. Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells. Cell Cycle 2011 May;10(9):1488-98
Villasante A et al
2011/01/01
Species: Mouse, Applications: ICC/IF PubMed
7 Wernig M et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson"s disease. Proc. Natl. Acad. Sci. U.S.A. 2008 Apr;105(15):5856-61
Wernig M et al
2008/01/01
PubMed
8 Madan B et al. The pluripotency-associated gene Dppa4 is dispensable for embryonic stem cell identity and germ cell development but essential for embryogenesis. Mol. Cell. Biol. 2009 Jun;29(11):3186-203
Madan B et al
2009/01/01
PubMed
9 Tejedo JR et al. Low concentrations of nitric oxide delay the differentiation of embryonic stem cells and promote their survival. Cell Death Dis 2010;1:e80
Tejedo JR et al
2010/01/01
PubMed
10 Schneider RP et al. TRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells. Nat Commun 2013;4:1946
Schneider RP et al
2013/01/01
Species: Mouse, Applications: FLOW, ChIP PubMed
11 Kohler EE et al. NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis. Blood 2011 Feb;117(5):1761-9
Kohler EE et al
2011/01/01
PubMed
12 Quinlan MP et al. Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion. Mol. Cell. Biol. 2008 Apr;28(8):2659-74
Quinlan MP et al
2008/01/01
PubMed
13 Hough SR et al. Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog. Stem Cells 2006 Jun;24(6):1467-75
Hough SR et al
2006/01/01
PubMed
14 Liang J et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 2008 Jun;10(6):731-9
Liang J et al
2008/01/01
PubMed
15 Meissner A et al. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 2007 Oct;25(10):1177-81
Meissner A et al
2007/01/01
PubMed
16 Izadyar F et al. Generation of multipotent cell lines from a distinct population of male germ line stem cells. Reproduction 2008 Jun;135(6):771-84
Izadyar F et al
2008/01/01
PubMed
17 Cole MF et al. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev. 2008 Mar;22(6):746-55
Cole MF et al
2008/01/01
PubMed
18 Moretto-Zita M et al. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc. Natl. Acad. Sci. U.S.A. 2010 Jul;107(30):13312-7
Moretto-Zita M et al
2010/01/01
PubMed
19 Deshpande AM et al. Cdk2ap2 is a novel regulator for self-renewal of murine embryonic stem cells. Stem Cells Dev. 2012 Nov;21(16):3010-8
Deshpande AM et al
2012/01/01
PubMed
20 Wernig M et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007 Jul;448(7151):318-24
Wernig M et al
2007/01/01
PubMed
21 Shin J et al. Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice. Nature 2010 Oct;467(7318):977-81
Shin J et al
2010/01/01
PubMed
22 Hanna J et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009 Dec;462(7273):595-601
Hanna J et al
2009/01/01
PubMed
23 Abdelalim EM et al. NPR-A regulates self-renewal and pluripotency of embryonic stem cells. Cell Death Dis 2011;2:e127
Abdelalim EM et al
2011/01/01
PubMed
24 Schaniel C et al. Smarcc1/Baf155 couples self-renewal gene repression with changes in chromatin structure in mouse embryonic stem cells. Stem Cells 2009 Dec;27(12):2979-91
Schaniel C et al
2009/01/01
Species: Mouse, Applications: WB PubMed
25 Abad M et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 2013 Oct;502(7471):340-5
Abad M et al
2013/01/01
Species: Mouse, Applications: ICC/IF PubMed
26 Bertacchi M et al. The double inhibition of endogenously produced BMP and Wnt factors synergistically triggers dorsal telencephalic differentiation of mouse ES cells. Dev Neurobiol 2015 Jan;75(1):66-79
Bertacchi M et al
2015/01/01
Species: Mouse, Applications: ICC/IF PubMed
27 Carelli S et al. Characteristics and Properties of Mesenchymal Stem Cells Derived from Micro-fragmented Adipose Tissue. Cell Transplant 2014 May;
Carelli S et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
28 Vaz MA et al. Prognostic value of stem cell quantification in stage II colon cancer. PLoS ONE 2014;9(2):e88480
Vaz MA et al
2014/01/01
Species: Human, Applications: IHC-P PubMed
29 Palla AR et al. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas. Sci Rep 2015;5:10205
Palla AR et al
2015/01/01
Species: Mouse, Applications: IHC-P PubMed
30 Neri T et al. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts. Stem Cell Reports 2015 Oct;5(4):558-68
Neri T et al
2015/01/01
Species: Mouse, Applications: ICC/IF PubMed
31 Pandolfini L et al. RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells. Genome Biol. 2016;17(1):94
Pandolfini L et al
2016/01/01
PubMed
32 Kim J et al. Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells. Oncogene 2016 Mar;35(10):1334-40
Kim J et al
2016/01/01
PubMed
33 Veerapandian V et al. Directed Evolution of Reprogramming Factors by Cell Selection and Sequencing. Stem Cell Reports 2018 Aug;11(2):593-606
Veerapandian V et al
2018/01/01
Species: Mouse, Applications: ICC/IF PubMed
34 Lee J et al. Tousled-like kinase 1 is a negative regulator of core transcription factors in murine embryonic stem cells. Sci Rep 2018 01;8(1):334
Lee J et al
2018/01/01
Species: Mouse, Applications: ICC/IF, WB PubMed
35 Zhang N et al. miR‑146b‑5p promotes the neural conversion of pluripotent stem cells by targeting Smad4. Int. J. Mol. Med. 2017 Sep;40(3):814-824
Zhang N et al
2017/01/01
Species: Mouse, Applications: ICC/IF PubMed
36 Paulis M et al. Chromosome transplantation as a novel approach for correcting complex genomic disorders. Oncotarget 2015 Nov;6(34):35218-30
Paulis M et al
2015/01/01
ICC/IF PubMed
37 Hayward BE et al. A point mutation in the nuclease domain of MLH3 eliminates repeat expansions in a mouse stem cell model of the Fragile X-related disorders. Nucleic Acids Res 2020 08;48(14):7856-7863
Hayward BE et al
2020/01/01
PubMed
38 Malik V et al. Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2. Nat Commun 2019 08;10(1):3477
Malik V et al
2019/01/01
PubMed
39 Liu Z et al. Generation of Rybp homozygous knockout murine ES cell line GIBHe001-A-1 by using CRISPR/Cas9 technology. Stem Cell Res 2019 12;41:101638
Liu Z et al
2019/01/01
PubMed
40 Baruah J et al. Low-Level Nanog Expression in the Regulation of Quiescent Endothelium. Arterioscler Thromb Vasc Biol 2020 09;40(9):2244-2264
Baruah J et al
2020/01/01
PubMed
41 Sun H et al. Metabolic switch and epithelial-mesenchymal transition cooperate to regulate pluripotency. EMBO J 2020 04;39(8):e102961
Sun H et al
2020/01/01
PubMed
42 Piazzolla D et al. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia. Nat Commun 2014;5:4226
Piazzolla D et al
2014/01/01
PubMed
43 Yao M et al. Knockout of Dip2c in murine ES cell line IBMSe001-B-1 by CRISPR/Cas9 genome editing technology. Stem Cell Res 2021 05;53:102236
Yao M et al
2021/01/01
PubMed
44 Li W et al. NADPH levels affect cellular epigenetic state by inhibiting HDAC3-Ncor complex. Nat Metab 2021 01;3(1):75-89
Li W et al
2021/01/01
PubMed
45 Ocampo A et al. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell 2016 Dec;167(7):1719-1733.e12
Ocampo A et al
2016/01/01
PubMed
  • No.: 1
  • 文献情報:
    Castiglioni V et al. Induced pluripotent stem cell lines from Huntington"s disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway. Neurobiol. Dis. 2012 Apr;46(1):30-40
    Castiglioni V et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Mari坦n RM et al. Suv4-20h abrogation enhances telomere elongation during reprogramming and confers a higher tumorigenic potential to iPS cells. PLoS ONE 2011;6(10):e25680
    Mari坦n RM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Camnasio S et al. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington"s disease patients demonstrates mutation related enhanced lysosomal activity. Neurobiol. Dis. 2012 Apr;46(1):41-51
    Camnasio S et al
    2012/01/01
  • 備考:
    Applications: ICC, IF, Species: Human
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Liu SP et al. n-Butylidenephthalide (BP) maintains stem cell pluripotency by activating Jak2/Stat3 pathway and increases the efficiency of iPS cells generation. PLoS ONE 2012;7(9):e44024
    Liu SP et al
    2012/01/01
  • 備考:
    Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Bertacchi M et al. The positional identity of mouse ES cell-generated neurons is affected by BMP signaling. Cell. Mol. Life Sci. 2012 Oct;
    Bertacchi M et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Villasante A et al. Epigenetic regulation of Nanog expression by Ezh2 in pluripotent stem cells. Cell Cycle 2011 May;10(9):1488-98
    Villasante A et al
    2011/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Wernig M et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson"s disease. Proc. Natl. Acad. Sci. U.S.A. 2008 Apr;105(15):5856-61
    Wernig M et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Madan B et al. The pluripotency-associated gene Dppa4 is dispensable for embryonic stem cell identity and germ cell development but essential for embryogenesis. Mol. Cell. Biol. 2009 Jun;29(11):3186-203
    Madan B et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Tejedo JR et al. Low concentrations of nitric oxide delay the differentiation of embryonic stem cells and promote their survival. Cell Death Dis 2010;1:e80
    Tejedo JR et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Schneider RP et al. TRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells. Nat Commun 2013;4:1946
    Schneider RP et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: FLOW, ChIP
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Kohler EE et al. NANOG induction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis. Blood 2011 Feb;117(5):1761-9
    Kohler EE et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Quinlan MP et al. Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion. Mol. Cell. Biol. 2008 Apr;28(8):2659-74
    Quinlan MP et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Hough SR et al. Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog. Stem Cells 2006 Jun;24(6):1467-75
    Hough SR et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Liang J et al. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 2008 Jun;10(6):731-9
    Liang J et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Meissner A et al. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 2007 Oct;25(10):1177-81
    Meissner A et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Izadyar F et al. Generation of multipotent cell lines from a distinct population of male germ line stem cells. Reproduction 2008 Jun;135(6):771-84
    Izadyar F et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Cole MF et al. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev. 2008 Mar;22(6):746-55
    Cole MF et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Moretto-Zita M et al. Phosphorylation stabilizes Nanog by promoting its interaction with Pin1. Proc. Natl. Acad. Sci. U.S.A. 2010 Jul;107(30):13312-7
    Moretto-Zita M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Deshpande AM et al. Cdk2ap2 is a novel regulator for self-renewal of murine embryonic stem cells. Stem Cells Dev. 2012 Nov;21(16):3010-8
    Deshpande AM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Wernig M et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007 Jul;448(7151):318-24
    Wernig M et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Shin J et al. Maternal Rnf12/RLIM is required for imprinted X-chromosome inactivation in mice. Nature 2010 Oct;467(7318):977-81
    Shin J et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Hanna J et al. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009 Dec;462(7273):595-601
    Hanna J et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Abdelalim EM et al. NPR-A regulates self-renewal and pluripotency of embryonic stem cells. Cell Death Dis 2011;2:e127
    Abdelalim EM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Schaniel C et al. Smarcc1/Baf155 couples self-renewal gene repression with changes in chromatin structure in mouse embryonic stem cells. Stem Cells 2009 Dec;27(12):2979-91
    Schaniel C et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Abad M et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 2013 Oct;502(7471):340-5
    Abad M et al
    2013/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Bertacchi M et al. The double inhibition of endogenously produced BMP and Wnt factors synergistically triggers dorsal telencephalic differentiation of mouse ES cells. Dev Neurobiol 2015 Jan;75(1):66-79
    Bertacchi M et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Carelli S et al. Characteristics and Properties of Mesenchymal Stem Cells Derived from Micro-fragmented Adipose Tissue. Cell Transplant 2014 May;
    Carelli S et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Vaz MA et al. Prognostic value of stem cell quantification in stage II colon cancer. PLoS ONE 2014;9(2):e88480
    Vaz MA et al
    2014/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Palla AR et al. The pluripotency factor NANOG promotes the formation of squamous cell carcinomas. Sci Rep 2015;5:10205
    Palla AR et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Neri T et al. Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional Osteoclasts. Stem Cell Reports 2015 Oct;5(4):558-68
    Neri T et al
    2015/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Pandolfini L et al. RISC-mediated control of selected chromatin regulators stabilizes ground state pluripotency of mouse embryonic stem cells. Genome Biol. 2016;17(1):94
    Pandolfini L et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Kim J et al. Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells. Oncogene 2016 Mar;35(10):1334-40
    Kim J et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Veerapandian V et al. Directed Evolution of Reprogramming Factors by Cell Selection and Sequencing. Stem Cell Reports 2018 Aug;11(2):593-606
    Veerapandian V et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Lee J et al. Tousled-like kinase 1 is a negative regulator of core transcription factors in murine embryonic stem cells. Sci Rep 2018 01;8(1):334
    Lee J et al
    2018/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF, WB
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Zhang N et al. miR‑146b‑5p promotes the neural conversion of pluripotent stem cells by targeting Smad4. Int. J. Mol. Med. 2017 Sep;40(3):814-824
    Zhang N et al
    2017/01/01
  • 備考:
    Species: Mouse, Applications: ICC/IF
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Paulis M et al. Chromosome transplantation as a novel approach for correcting complex genomic disorders. Oncotarget 2015 Nov;6(34):35218-30
    Paulis M et al
    2015/01/01
  • 備考:
    ICC/IF
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Hayward BE et al. A point mutation in the nuclease domain of MLH3 eliminates repeat expansions in a mouse stem cell model of the Fragile X-related disorders. Nucleic Acids Res 2020 08;48(14):7856-7863
    Hayward BE et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Malik V et al. Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2. Nat Commun 2019 08;10(1):3477
    Malik V et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Liu Z et al. Generation of Rybp homozygous knockout murine ES cell line GIBHe001-A-1 by using CRISPR/Cas9 technology. Stem Cell Res 2019 12;41:101638
    Liu Z et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Baruah J et al. Low-Level Nanog Expression in the Regulation of Quiescent Endothelium. Arterioscler Thromb Vasc Biol 2020 09;40(9):2244-2264
    Baruah J et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Sun H et al. Metabolic switch and epithelial-mesenchymal transition cooperate to regulate pluripotency. EMBO J 2020 04;39(8):e102961
    Sun H et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Piazzolla D et al. Lineage-restricted function of the pluripotency factor NANOG in stratified epithelia. Nat Commun 2014;5:4226
    Piazzolla D et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Yao M et al. Knockout of Dip2c in murine ES cell line IBMSe001-B-1 by CRISPR/Cas9 genome editing technology. Stem Cell Res 2021 05;53:102236
    Yao M et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Li W et al. NADPH levels affect cellular epigenetic state by inhibiting HDAC3-Ncor complex. Nat Metab 2021 01;3(1):75-89
    Li W et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Ocampo A et al. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell 2016 Dec;167(7):1719-1733.e12
    Ocampo A et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed